We are live on ! Find out more
EWA

EverSource Wealth Advisors Portfolio holdings

AUM $2.97B
1-Year Est. Return 28.74%
This Fund
S&P 500
This Quarter Est. Return
+2.58%
1 Year Est. Return
+28.74%
3 Year Est. Return
+89.7%
5 Year Est. Return
10 Year Est. Return
AUM
$2.72B
AUM Growth
+$190M
Cap. Flow
+$157M
Cap. Flow %
5.78%
Top 10 Hldgs %
20.63%
Holding
4,507
New
186
Increased
1,795
Reduced
1,792
Closed
236

Sector Composition

Rank Sector Weight
1 Technology 12.21%
2 Financials 7.71%
3 Consumer Discretionary 5.3%
4 Industrials 3.51%
5 Communication Services 3.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EB
2701
DELISTED
Eventbrite
EB
$12.1K ﹤0.01%
2,709
-572
-17% -$1.77K
RMAX icon
2702
RE/MAX Holdings
RMAX
$200M
$12K ﹤0.01%
1,587
+1,016
+178% +$8.24K
MBSD icon
2703
FlexShares Disciplined Duration MBS Index Fund
MBSD
$89M
$12K ﹤0.01%
579
CZFS icon
2704
Citizens Financial Services
CZFS
$369M
$11.9K ﹤0.01%
209
-30
-13% -$1.71K
PGY icon
2705
Pagaya Technologies
PGY
$1.34B
$11.9K ﹤0.01%
570
+45
+9% +$1.15K
AVO icon
2706
Mission Produce
AVO
$1.13B
$11.9K ﹤0.01%
1,026
-88
-8% -$1.05K
UDEC
2707
Innovator US Equity Ultra Buffer ETF December
UDEC
$247M
$11.9K ﹤0.01%
300
NBTX
2708
Nanobiotix
NBTX
$1.91B
$11.9K ﹤0.01%
514
AHRT
2709
AH Realty Trust
AHRT
$542M
$11.9K ﹤0.01%
1,791
-963
-35% -$6.36K
ROG icon
2710
Rogers Corp
ROG
$2.2B
$11.8K ﹤0.01%
129
-47
-27% -$4.04K
LEVI icon
2711
Levi Strauss
LEVI
$9.46B
$11.8K ﹤0.01%
569
+23
+4% +$496
CBAN icon
2712
Colony Bankcorp
CBAN
$468M
$11.8K ﹤0.01%
662
-16
-2% -$271
MLTX icon
2713
MoonLake Immunotherapeutics
MLTX
$1.59B
$11.8K ﹤0.01%
893
+885
+11,063% +$10.4K
ANRO icon
2714
Alto Neuroscience
ANRO
$1.07B
$11.8K ﹤0.01%
661
-64
-9% -$806
BSRR icon
2715
Sierra Bancorp
BSRR
$530M
$11.7K ﹤0.01%
358
+243
+211% +$7.35K
PRDO icon
2716
Perdoceo Education
PRDO
$2.14B
$11.7K ﹤0.01%
398
-67
-14% -$2.12K
IDEV icon
2717
iShares Core MSCI International Developed Markets ETF
IDEV
$31.1B
$11.6K ﹤0.01%
141
MNRO icon
2718
Monro
MNRO
$465M
$11.6K ﹤0.01%
578
+138
+31% +$2.54K
RGC icon
2719
Regencell Bioscience
RGC
$2.9B
$11.6K ﹤0.01%
+550
New +$8.94K
CX icon
2720
Cemex
CX
$17.2B
$11.5K ﹤0.01%
1,005
+103
+11% +$1.06K
RXRX icon
2721
Recursion Pharmaceuticals
RXRX
$1.59B
$11.5K ﹤0.01%
2,805
-6,100
-69% -$30.2K
HLIT icon
2722
Harmonic Inc
HLIT
$1.16B
$11.4K ﹤0.01%
1,156
+129
+13% +$1.3K
UUUU icon
2723
Energy Fuels
UUUU
$2.82B
$11.4K ﹤0.01%
783
+46
+6% +$781
BGC icon
2724
BGC Group
BGC
$5.73B
$11.4K ﹤0.01%
1,272
-6,109
-83% -$55K
CGON icon
2725
CG Oncology
CGON
$6.19B
$11.3K ﹤0.01%
273

Similar funds

EverSource Wealth Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, EverSource Wealth Advisors held 4,507 positions worth $2.72B, up 7.5% from $2.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

EverSource Wealth Advisors deployed $157M of net new capital in Q4 2025, opening 186 new positions and adding to 1,795 existing holdings. Its largest new stake was T. Rowe Price Blue Chip Growth ETF: 48,629 shares worth $2.42M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Sovereign's Capital Flourish Fund, an estimated $8.36M trimmed.

  • EverSource Wealth Advisors's largest Q4 2025 buy was T. Rowe Price Blue Chip Growth ETF: 48,629 shares worth $2.42M.
  • EverSource Wealth Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2025, an estimated $17.8M increase.
  • EverSource Wealth Advisors's biggest Q4 2025 reduction was Sovereign's Capital Flourish Fund, cutting an estimated $8.36M.
  • EverSource Wealth Advisors fully exited Direxion Daily Technology Bear 3x ETF in Q4 2025, selling an estimated $882K.
  • EverSource Wealth Advisors's ten largest holdings make up 21% of its $2.72B portfolio in Q4 2025.
  • EverSource Wealth Advisors opened 186 new positions and closed 236 in Q4 2025.
  • EverSource Wealth Advisors's portfolio value rose 7.5% quarter-over-quarter to $2.72B.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.